Pfizer

News

Trailing its RSV vaccine rivals, Bavarian Nordic cuts China ...

Bavarian Nordic has licensed rights to its respiratory syncytial virus (RSV) vaccine in China and certain other Asian markets to Shanghai's Nuance Pharma in a $225 million deal.

News

Moderna follows Pfizer in asking FDA for second COVID booste...

Moderna has asked the FDA for emergency use authorisation for a fourth dose of its mRNA COVID-19 vaccine SpikeVax, following in the footsteps of Pfizer/BioNTech, which filed their Comirnaty

News

Alnylam sues Pfizer, Moderna over COVID-19 vaccines

Alnylam claims it is owed a slice of the massive revenues booked by Pfizer and Moderna for their mRNA-based COVID-19 vaccines, because they are both infringing patents its holds on a delive

News

Pfizer makes case for fourth COVID jab dose to FDA

Earlier this week, Pfizer chief executive Albert Bourla said that a second booster of its COVID-19 vaccine will be necessary to keep the pandemic under control, and the company has now aske

News

Digital innovation drives vaccine development

COVID vaccines not linked to excess deaths, says CDC

There is no evidence that vaccination with either the Pfizer/BioNTech or Moderna's mRNA-based COVID-19 vaccines led to the death of patients, says a study by researchers at the Centres for

News

After GSK stumble, Pfizer moves forward with RSV vaccine

Pfizer has been awarded breakthrough status from the FDA for its respiratory syncytial virus (RSV) vaccine in pregnant women, putting the company in pole position to bring a shot to market

Trailing its RSV vaccine rivals, Bavarian Nordic cuts China ...

Moderna follows Pfizer in asking FDA for second COVID booste...

Alnylam sues Pfizer, Moderna over COVID-19 vaccines

Pfizer makes case for fourth COVID jab dose to FDA

COVID vaccines not linked to excess deaths, says CDC

After GSK stumble, Pfizer moves forward with RSV vaccine

BioMarin ends year with $4.8bn play for Amicus

How to meet your physicians where they are online

Pfizer

Editor's Picks